These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 979649)

  • 1. Effects of substance-P [PROCEEDINGS].
    Sasaki H
    Metabolism; 1976 Nov; 25(11 Suppl 1):1463. PubMed ID: 979649
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurotensin and substance-P: effects on plasma insulin and glucagon levels.
    Brown M; Villarreal J; Vale W
    Metabolism; 1976 Nov; 25(11 Suppl 1):1459-61. PubMed ID: 979648
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of substance P and neurotensin infused intrapancreatically on glucagon and insulin secretion.
    Kaneto A; Kaneko T; Kajinuma H; Kosaka K
    Endocrinology; 1978 Feb; 102(2):393-401. PubMed ID: 743963
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of oral glucose and protein load on plasma glucagon and insulin concentrations in small for gestational age infants.
    Salle BL; Ruiton-Ugliengo A
    Pediatr Res; 1977 Feb; 11(2):108-12. PubMed ID: 840499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of substance P on various vascular beds in the dog.
    Hallberg D; Pernow B
    Acta Physiol Scand; 1975 Feb; 93(2):277-85. PubMed ID: 1146575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of neurotensin and substance P on plasma insulin, glucagon and glucose levels.
    Brown M; Vale W
    Endocrinology; 1976 Mar; 98(3):819-22. PubMed ID: 1261503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased release of somatostatin into the portal vein following electrical vagal stimulation in the cat.
    Uvnäs-Wallensten K; Efendic S; Roovete A; Johansson C
    Acta Physiol Scand; 1980 Aug; 109(4):393-8. PubMed ID: 6110310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of neurotensin and substance P on insulin and glucagon release by the perfused dog pancreas [proceedings].
    Patton G; Brown M; Dobbs R; Vale W; Unger RH
    Metabolism; 1976 Nov; 25(11 Suppl 1):1465. PubMed ID: 790094
    [No Abstract]   [Full Text] [Related]  

  • 9. Persistent pancreatic glucagon but not insulin response to arginine in pancreatectomized dogs.
    Mashiter K; Harding PE; Chou M; Mashiter GD; Stout J; Diamond D; Field JB
    Endocrinology; 1975 Mar; 96(3):678-93. PubMed ID: 1116479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin and glucagon breakthrough of somatostatin suppression: importance of portal vein hormone measurements.
    Polonsky K; Jaspan J; Pugh W; Dhorajiwala J; Abraham M; Blix P; Moossa AR
    Diabetes; 1981 Aug; 30(8):664-9. PubMed ID: 6114006
    [No Abstract]   [Full Text] [Related]  

  • 11. [Action of glucagon on hepatosplanchnic, portal venous and hepatic arterial hemodynamics in the dog].
    Sardi GF; Pandolfo G; Brocchi G; Curti B; Chiandussi L
    Boll Soc Ital Biol Sper; 1969 Feb; 45(3):211-3. PubMed ID: 5346801
    [No Abstract]   [Full Text] [Related]  

  • 12. Pancreatic innervation is not essential for exercise-induced changes in glucagon and insulin or glucose kinetics.
    Coker RH; Koyama Y; Lacy DB; Williams PE; Rhèaume N; Wasserman DH
    Am J Physiol; 1999 Dec; 277(6):E1122-9. PubMed ID: 10600803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal/pancreatic hormone concentrations in the portal venous system of nine patients with organic hyperinsulinism.
    Glaser B; Valtysson G; Fajans SS; Vinik AI; Cho K; Thompson N
    Metabolism; 1981 Oct; 30(10):1001-10. PubMed ID: 6116152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of glucagon on hepatic blood flow. An experimental study in the dog.
    Kock NG; Roding B; Hahnloser P; Tibblin S; Schenk WG
    Arch Surg; 1970 Feb; 100(2):147-9. PubMed ID: 5411406
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison studies of neurotensin and xenopsin upon pancreatic secretion in the dog [proceedings].
    Ishida T; Kawamura K; Goto A; Nishina Y; Takahara J
    Metabolism; 1976 Nov; 25(11 Suppl 1):1467. PubMed ID: 790095
    [No Abstract]   [Full Text] [Related]  

  • 16. Fasting and postabsorptive hepatic glucose and insulin metabolism in hyperthyroidism.
    Raboudi N; Arem R; Jones RH; Chap Z; Pena J; Chou J; Field JB
    Am J Physiol; 1989 Jan; 256(1 Pt 1):E159-66. PubMed ID: 2643338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transhepatic changes in insulin and glucagon following partial hepatectomy in the pig.
    Kahn D; van Hoorn-Hickman R; Terblanche J; Child P
    Surg Gynecol Obstet; 1984 May; 158(5):475-81. PubMed ID: 6231738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ouabain on cardiac output and pulmonary blood flow in dogs.
    Treat E; Ulano H; Pfeffer M; Massion W; Shanbour LL; Jacobson ED
    Am Heart J; 1972 Sep; 84(3):371-6. PubMed ID: 5075645
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of somatostatin-14 and somatostatin-28 on bombesin-stimulated release of gastrin, insulin, and glucagon in the dog.
    Vaysse N; Pradayrol L; Chayvialle JA; Pignal F; Esteve JP; Susini C; Descos F; Ribet A
    Endocrinology; 1981 May; 108(5):1843-7. PubMed ID: 6111446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of oral, peripheral intravenous, and intraportal glucose on hepatic glucose uptake and insulin and glucagon extraction in conscious dogs.
    Ishida T; Chap Z; Chou J; Lewis R; Hartley C; Entman M; Field JB
    J Clin Invest; 1983 Aug; 72(2):590-601. PubMed ID: 6348094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.